AstraZeneca AB | Detailed information

AstraZeneca AB - Detailed information

Start page > The largest companies in the Nordic countries by t. . . > AstraZeneca AB


AstraZeneca AB	Press releases from Newsdesk

Business ID:	556011-7482
Company:	AstraZeneca AB
	SE-151 85 Södertälje
County:	Stockholms län
Telephone:	+46 (0)8-55326000
Fax:	Access required
E-mail:	Access required
Website:	Access required

Chairman of the board:	Access required
Managing Director/CEO:	Jan Lundberg

Established:

Access required

Subsidiary company to:

Access required

Stock-exchange listing:

Access required

Rank in the Nordic countries (incl. subsidiaries) by

Net turnover

Access required

Click for more rankings

Rank in the Nordic countries (incl. subsidiaries) by

[Close]

Exports	Access required
Net profit	Access required
Number of employees	Access required
Total assets	Access required
Foreign sales	Access required

Industry sector:

B24

Manufacture of chemicals and chemical products

Activity code:

244

Manufacture of pharmaceuticals, medicinal chemicals and botanical products

Rank in industry in the Nordic countries by :

Net turnover

Access required

Click for more rankings

Rank in industry in the Nordic countries by

[Close]

Industry sector:	B24	Manufacture of chemicals and chemical products
Rank in industry in the Nordic countries by:
Total assets		Access required
Foreign sales		Access required
Profitability		Access required
Solvency		Access required
Return on assets (ROA)		Access required
Return on equity (ROE)		Access required
Exports		Access required
Net profit		Access required
Number of employees		Access required

Closing information (x1000 EUR)
Fiscal year	200712	200612	200512
Net turnover	4.368.818	Access required	Access required
- exports	Access required	Access required	Access required
Foreign sales	Access required	Access required	Access required
Financial expenses	Access required	Access required	Access required
Earnings before taxes	Access required	Access required	Access required
Total assets	Access required	Access required	Access required
Current assets	Access required	Access required	Access required
Current liabilities	Access required	Access required	Access required
Equity capital	Access required	Access required	Access required
- share capital	Access required	Access required	Access required
Employees (average)	Access required	Access required	Access required
- in Sweden	Access required	Access required	Access required
- abroad	Access required	Access required	Access required
Shareholders	Access required	Access required	Access required
Investments in fixed assets	Access required	Access required	Access required

Financial ratios
Solvency	Access required	Access required	Access required
Turnover per employee	Access required	Access required	Access required
Earnings as % of turnover	Access required	Access required	Access required
Return on assets (ROA)	Access required	Access required	Access required
Current ratio	Access required	Access required	Access required
Return on equity (ROE)	Access required	Access required	Access required

Closing figures are converted from local currency to euros according to the exchange rate on closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from UC (Sweden), CreditInform (Norway), KOB (Denmark) and Asiakastieto (Finland).

Press releases from Newsdesk

AstraZeneca och Targacept informerar om de första resultaten från en studie i fas 2b gällande AZD3480 vid Alzheimers sjukdom

Alphabetical company index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Å Ä Ö Other